137 related articles for article (PubMed ID: 10319414)
1. Comparison of enzymatic activities of the HIV-1 and HFV integrases to their U5 LTR substrates.
Oh YT; Shin CG
Biochem Mol Biol Int; 1999 Apr; 47(4):621-9. PubMed ID: 10319414
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the functional domains of human foamy virus integrase using chimeric integrases.
Lee HS; Kang SY; Shin CG
Mol Cells; 2005 Apr; 19(2):246-55. PubMed ID: 15879710
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the human spuma retrovirus integrase by site-directed mutagenesis, by complementation analysis, and by swapping the zinc finger domain of HIV-1.
Pahl A; Flügel RM
J Biol Chem; 1995 Feb; 270(7):2957-66. PubMed ID: 7852375
[TBL] [Abstract][Full Text] [Related]
4. Endonucleolytic cleavages and DNA-joining activities of the integration protein of human foamy virus.
Pahl A; Flügel RM
J Virol; 1993 Sep; 67(9):5426-34. PubMed ID: 7688824
[TBL] [Abstract][Full Text] [Related]
5. Functional nucleotides of U5 LTR determining substrate specificity of prototype foamy virus integrase.
Kang SY; Ahn DG; Lee C; Lee YS; Shin CG
J Microbiol Biotechnol; 2008 Jun; 18(6):1044-9. PubMed ID: 18600045
[TBL] [Abstract][Full Text] [Related]
6. Mapping viral DNA specificity to the central region of integrase by using functional human immunodeficiency virus type 1/visna virus chimeric proteins.
Katzman M; Sudol M
J Virol; 1998 Mar; 72(3):1744-53. PubMed ID: 9499023
[TBL] [Abstract][Full Text] [Related]
7. Human foamy virus integrase fails to catalyse the integration of a circular DNA molecule containing an LTR junction sequence.
Russell RA; Critchley R; Vassaux G; McClure MO
Gene Ther; 2002 Oct; 9(19):1326-32. PubMed ID: 12224016
[TBL] [Abstract][Full Text] [Related]
8. Influence of subterminal viral DNA nucleotides on differential susceptibility to cleavage by human immunodeficiency virus type 1 and visna virus integrases.
Katzman M; Sudol M
J Virol; 1996 Dec; 70(12):9069-73. PubMed ID: 8971046
[TBL] [Abstract][Full Text] [Related]
9. Characterization of biochemical properties of feline foamy virus integrase.
Lee D; Hyun U; Kim JY; Shin CG
J Microbiol Biotechnol; 2010 Jun; 20(6):968-73. PubMed ID: 20622493
[TBL] [Abstract][Full Text] [Related]
10. Activity of recombinant HIV-1 integrase on mini-HIV DNA.
Cherepanov P; Surratt D; Toelen J; Pluymers W; Griffith J; De Clercq E; Debyser Z
Nucleic Acids Res; 1999 May; 27(10):2202-10. PubMed ID: 10219094
[TBL] [Abstract][Full Text] [Related]
11. Substrate specificity of recombinant human immunodeficiency virus integrase protein.
LaFemina RL; Callahan PL; Cordingley MG
J Virol; 1991 Oct; 65(10):5624-30. PubMed ID: 1895409
[TBL] [Abstract][Full Text] [Related]
12. Expression and characterization of the integrase of bovine immunodeficiency virus.
Avidan O; Hizi A
Virology; 2008 Feb; 371(2):309-21. PubMed ID: 17976681
[TBL] [Abstract][Full Text] [Related]
13. Prototype foamy virus integrase is promiscuous for target choice.
Mackler RM; Lopez MA; Osterhage MJ; Yoder KE
Biochem Biophys Res Commun; 2018 Sep; 503(3):1241-1246. PubMed ID: 30017200
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the integrase of human immunodeficiency virus (HIV) type 1 by anti-HIV plant proteins MAP30 and GAP31.
Lee-Huang S; Huang PL; Huang PL; Bourinbaiar AS; Chen HC; Kung HF
Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8818-22. PubMed ID: 7568024
[TBL] [Abstract][Full Text] [Related]
15. Directed DNA shuffling of retrovirus and retrotransposon integrase protein domains.
Qi X; Vargas E; Larsen L; Knapp W; Hatfield GW; Lathrop R; Sandmeyer S
PLoS One; 2013; 8(5):e63957. PubMed ID: 23691126
[TBL] [Abstract][Full Text] [Related]
16. Mapping target site selection for the non-specific nuclease activities of retroviral integrase.
Katzman M; Sudol M; Pufnock JS; Zeto S; Skinner LM
Virus Res; 2000 Jan; 66(1):87-100. PubMed ID: 10653920
[TBL] [Abstract][Full Text] [Related]
17. Characterization of recombinant integrase of human immunodeficiency virus type 1 (isolate Bru).
Semenova EA; Gashnikova NM; Il'ina TV; Pronyaeva TR; Pokrovsky AG
Biochemistry (Mosc); 2003 Sep; 68(9):988-93. PubMed ID: 14606941
[TBL] [Abstract][Full Text] [Related]
18. The use of a new in vitro reaction substrate reproducing both U3 and U5 regions of the HIV-1 3'-ends increases the correlation between the in vitro and in vivo effects of the HIV-1 integrase inhibitors.
Tramontano E; Onidi L; Esposito F; Badas R; La Colla P
Biochem Pharmacol; 2004 May; 67(9):1751-61. PubMed ID: 15081874
[TBL] [Abstract][Full Text] [Related]
19. Two-long terminal repeat (LTR) DNA circles are a substrate for HIV-1 integrase.
Richetta C; Thierry S; Thierry E; Lesbats P; Lapaillerie D; Munir S; Subra F; Leh H; Deprez E; Parissi V; Delelis O
J Biol Chem; 2019 May; 294(20):8286-8295. PubMed ID: 30971426
[TBL] [Abstract][Full Text] [Related]
20. Characterization of chimeric enzymes between caprine arthritis--encephalitis virus, maedi--visna virus and human immunodeficiency virus type 1 integrases expressed in Escherichia coli.
Berger N; Heller AE; Störmann KD; Pfaff E
J Gen Virol; 2001 Jan; 82(Pt 1):139-148. PubMed ID: 11125167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
